CHRNA7 and Alzheimer disease: In an early study, we found that statins, both lipophilic and hydrophilic, induce high expression of α7 nAChR, decrease cholinesterase activities, and increase the level αAPPs in SH‐SY5Y cells, indicating that these drugs might be able to play an important neuroprotective role in connection with treatment of AD [111].